Omega Fund Management, LLC Nuvation Bio Inc. Transaction History
Omega Fund Management, LLC
- $48.5 Million
- Q1 2025
A detailed history of Omega Fund Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Omega Fund Management, LLC holds 13,072,340 shares of NUVB stock, worth $28.4 Million. This represents 47.43% of its overall portfolio holdings.
Number of Shares
13,072,340Holding current value
$28.4 Million% of portfolio
47.43%Shares
9 transactions
Others Institutions Holding NUVB
# of Institutions
167Shares Held
156MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$56.3 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$35.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$33.4 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$21.4 Million0.45% of portfolio
-
Octagon Capital Advisors LP New York, NY7.9MShares$17.1 Million4.63% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $471M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...